Charles J. Dockendorff

Sits on 3 boards. Last updated September 27, 2026

Time on boards

Boards served
3
Current seats
3
Board service
10 years
Director since
2023

10 years of board service in total across 3 boards, counting each seat separately. Longest: Keysight Technologies Inc., 3 years.

3 years ยท Since 2023
3 years ยท Since 2023
3 years ยท Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Mar 20, 2026 Keysight Technologies Inc. Grant or award +870 โ€” โ€”
Jul 24, 2025 Haemonetics Corporation Grant or award +2,693 โ€” โ€”
Mar 21, 2025 Keysight Technologies Inc. Grant or award +1,589 โ€” โ€”
Jul 25, 2024 Haemonetics Corporation Grant or award +2,207 โ€” โ€”
May 9, 2024 Boston Scientific Corporation Grant or award +2,901 โ€” โ€”
May 7, 2024 Boston Scientific Corporation Open-market sale โˆ’3,946 $72.70 $286,874
Mar 22, 2024 Keysight Technologies Inc. Grant or award +1,632 โ€” โ€”
Sep 5, 2023 Haemonetics Corporation Open-market sale โˆ’10,215 $87.68 $895,651
Aug 18, 2023 Boston Scientific Corporation Open-market sale โˆ’17,079 $50.74 $866,588
Aug 4, 2023 Haemonetics Corporation Grant or award +2,226 โ€” โ€”
May 4, 2023 Boston Scientific Corporation Grant or award +3,946 โ€” โ€”
Mar 17, 2023 Keysight Technologies Inc. Grant or award +1,543 โ€” โ€”
Jan 6, 2023 Keysight Technologies Inc. Gift โˆ’2,844 โ€” โ€”
Jan 6, 2023 Boston Scientific Corporation Gift โˆ’8,201 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.